Drug Profile
Bumetanide - Only For Children Pharmaceuticals/Swedish Orphan Biovitrum
Alternative Names: Bumetanide - Only For Children Pharmaceuticals/Swedish Orphan Biovitrum (Sobi)Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Only for Children Pharmaceuticals
- Class Antihypertensives; Antiparkinsonians; Behavioural disorder therapies; Benzoic acids; Heart failure therapies; Sulfonamides
- Mechanism of Action Ion pump modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Neonatal seizures
Most Recent Events
- 30 Aug 2011 Phase-I/II clinical trials in Neonatal seizures in Finland (IV)
- 30 Aug 2011 Phase-I/II clinical trials in Neonatal seizures in Ireland (IV)
- 30 Aug 2011 Phase-I/II clinical trials in Neonatal seizures in Netherlands (IV)